ReAlta Life Sciences said it appointment Lewis T. “Rusty” Williams, M.D., Ph.D. as Chairman of its Board of Directors, as it continues to rebalance the inflammatory response to address rare and acute inflammatory diseases across a wide spectrum of therapeutic areas.
The company said Edward A. “Buzz” Heidt Jr., who has served as Chairman since 2020, will continue to serve as a member of the Board of Directors.
“We are delighted to welcome Dr. Williams as Chairman of our Board of Directors,” said David Marek, Chief Executive Officer of ReAlta. “His exceptional track record in building successful biopharmaceutical companies and expertise in drug development will be invaluable as ReAlta advances its clinical programs.”
Contact:
Editor@Executives-edge.com
